Monocytosis and Culprit Vessel in STEMI Patients

Completed

Conditions studied: STEMI

In brief

Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST segment elevation myocardial infarction. A monocyte count of greater than 800/mm3 following acute myocardial infarction has been shown to be associated with increased incidence of left ventricular dysfunction. The investigators study would retrospectively collect data on patients with ST elevation myocardial infarction, looking for an association between high monocyte count and the culprit vessel causing the myocardial infarction. The investigators would also investigate whether monocytosis would be a marker of poor prognosis.

Key facts

Study ID

NCT01569646

Run by

Northwell Health

People needed

226

Starts

2008-04-01

Last updated by the study team

2012-04-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• STEMI

You may not qualify if…

• Patients on antibiotics and steroids

Where it is running

• Staten Island University Hospital — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.